J.W. Burns & Co’s Medifast MED Stock Holding History

J.W. Burns & Co’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,900	Closed	-$217K	–	184
2023 Q3	$217K	Hold	2,900	–	–	0.04%	172
2023 Q2	$267K	Hold	2,900	–	–	0.04%	155
2023 Q1	$301K	Hold	2,900	–	–	0.05%	149
2022 Q4	$335K	Hold	2,900	–	–	0.06%	142
2022 Q3	$314K	Hold	2,900	–	–	0.06%	140
2022 Q2	$523K	Sell	2,900 -200	-6%	-$35.8K	0.1%	112
2022 Q1	$529K	Hold	3,100	–	–	0.08%	124
2021 Q4	$649K	Hold	3,100	–	–	0.09%	117
2021 Q3	$597K	Sell	3,100 -100	-3%	-$24.6K	0.09%	118
2021 Q2	$906K	Sell	3,200 -50	-2%	-$13.5K	0.14%	100
2021 Q1	$688K	Hold	3,250	–	–	0.12%	111
2020 Q4	$638K	Hold	3,250	–	–	0.11%	111
2020 Q3	$534K	Hold	3,250	–	–	0.11%	108
2020 Q2	$451K	Hold	3,250	–	–	0.1%	112
2020 Q1	$203K	Hold	3,250	–	–	0.05%	137
2019 Q4	$356K	Hold	3,250	–	–	0.08%	131
2019 Q3	$337K	Hold	3,250	–	–	0.08%	132
2019 Q2	$417K	Sell	3,250 -127	-4%	-$17.6K	0.1%	122
2019 Q1	$431K	Hold	3,377	–	–	0.11%	118
2018 Q4	$422K	Hold	3,377	–	–	0.12%	117
2018 Q3	$748K	Buy	3,377 +127	+4%	+$25.7K	0.18%	104
2018 Q2	$521K	Hold	3,250	–	–	0.13%	113
2018 Q1	$304K	Hold	3,250	–	–	0.08%	137
2017 Q4	$227K	Buy	+3,250	New	+$216K	0.06%	144

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

J.W. Burns & Co's MED Position: Q4 2023 in Review

J.W. Burns & Co sold out of Medifast (MED) in Q4 2023, closing a stake of 2,900 shares — an estimated $217K sold.

J.W. Burns & Co first reported a position in MED in Q4 2017 and held it in 24 quarters. The position peaked at $906K in Q2 2021. 216 funds tracked by Wall St. Rank hold MED as of Q4 2023.

J.W. Burns & Co reported no remaining Medifast position as of Q4 2023 after selling out during the quarter.
J.W. Burns & Co sold 2,900 Medifast shares in Q4 2023, an estimated $217K.
J.W. Burns & Co first reported a position in Medifast in Q4 2017 and held it in 24 quarters.
J.W. Burns & Co's Medifast position peaked at $906K in Q2 2021.
216 funds tracked by Wall St. Rank held Medifast as of Q4 2023.

Based on J.W. Burns & Co's 13F filing for Q4 2023, filed 18 Jan 2024.